The EBV peptide pool contains 44 peptides (8-21mer) from Human herpesvirus 4 (Epstein Barr virus), derived from the following protein
BARF1 protein
BZLF1
DNA polymerase catalytic subunit
EBNA-1 (Epstein-Barr nuclear antigen 1)
EBNA-2
EBNA-3A
EBNA-3B
EBNA-6
Glycoprotein GP110 precursor (MTP, p140)
Large tegument protein deneddylase
LMP1 (Latent membrane protein 1)
LMP2A/B
Envelope membrane glycoprotein GP350
Transcription activator BRLF1
The peptide sequences are a mixture of MHC class–I & MHC class–II epitopes. The purity of each peptide is ≥90% (HPLC-MS).
Application
The in-vitro stimulation of Peripheral Blood Mononuclear Cells (PBMCs) with EBV ImmuneSelect Peptide Pool activates memory T cells specific to the virus, leading to cytokine secretion and the increased expression of specific surface markers.
£195.00
Product Details
Amount
7 nmol/peptide (approx. 11.6 ug), for the stimulation of up to 1.10^8 cells